home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9605d.zip
/
M9650997.TXT
< prev
next >
Wrap
Text File
|
1996-03-30
|
3KB
|
47 lines
Document 0997
DOCN M9650997
TI Sinusitis in children infected with human immunodeficiency virus:
clinical characteristics, risk factors, and prophylaxis. National
Institute of Child Health and Human Development Intravenous
Immunoglobulin Clinical Trial Study Group.
DT 9505
AU Mofenson LM; Korelitz J; Pelton S; Moye J Jr; Nugent R; Bethel J;
Pediatric, Adolescent, and Maternal AIDS Branch, National; Institute of
Child Health and Human Development, National; Institutes of Health,
Bethesda, Maryland 20892-7510, USA.
SO Clin Infect Dis. 1995 Nov;21(5):1175-81. Unique Identifier : AIDSLINE
MED/96126000
AB The clinical presentation, radiological and laboratory evaluation,
treatment, and risk factors of sinusitis in a cohort of 376 human
immunodeficiency virus (HIV)-infected children from a placebo-controlled
clinical trial of intravenous immunoglobulin (IVIG) as prophylaxis for
infections were examined. Ninety-five episodes of sinusitis were
described in 60 patients; one-third of the patients had two or more
episodes. Sinusitis episodes were commonly associated with nonspecific,
chronic symptoms (67.4%, persistent nasal discharge; 54.7%, nocturnal or
persistent cough), whereas symptoms more specific to acute sinusitis
were less frequent (17.9%, headache or facial pain; 9.5%, periorbital
swelling; 25.3%, temperature of > or = 102 degrees F; 9%, total white
blood cell count of > or = 15,000/mm3). The sinuses primarily involved
were the maxillary sinus (85.9%) and the ethmoidal sinus (42.3%); 36% of
episodes involved two or more sinuses. Preceding respiratory infections
did not appear to increase the risk of sinusitis, and CD4+ lymphocyte
counts in children with and without sinusitis did not differ. Neither
monthly IVIG prophylaxis nor three times weekly
trimethoprimsulfamethoxazole prophylaxis for Pneumocystis carinii
pneumonia decreased the risk of sinusitis. Sinusitis in HIV-infected
children is most often subacute and recurrent. Evaluations of new
modalities for prophylaxis for sinusitis are needed.
DE Anti-Infective Agents/PHARMACOLOGY AIDS-Related Opportunistic
Infections/*COMPLICATIONS/DIAGNOSIS/ PREVENTION & CONTROL Case-Control
Studies Child Child, Preschool Cohort Studies Female Human
Immunoglobulins, Intravenous/PHARMACOLOGY Infant Male Recurrence
Risk Factors Sinusitis/*COMPLICATIONS/DIAGNOSIS/PREVENTION & CONTROL
Support, U.S. Gov't, P.H.S. Trimethoprim-Sulfamethoxazole
Combination/PHARMACOLOGY CLINICAL TRIAL JOURNAL ARTICLE RANDOMIZED
CONTROLLED TRIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).